Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia

Clinical trial NCT00607373 · COMPLETED

Trial details

NCT number: NCT00607373
Sponsor: Kastle Therapeutics, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lipid Metabolism, Inborn Errors Hypercholesterolemia, Autosomal Dominant Hyperlipidemias Metabolic Diseases Hyperlipoproteinemia Type II Metabolism, Inborn Errors Genetic Diseases, Inborn Infant, Newborn, Diseases Metabolic Disorder Congenital Abnormalities Hypercholesterolemia Hyperlipoproteinemias

Start date: 2007-07-01
Primary completion: 2009-03-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.